Spread of Extended-Spectrum Beta-Lactamase producing Escherichia coli clinical isolates in Sanandaj hospitals

Journal of Biological Sciences

Volumn 9, Issue 4, 2009, Pages 362-366

  Mansouri, M ^a   Ramazanzadeh, Rashid ^a  

^a KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibiotic resistance; ESBL; Escherichia coli; PCR

Indexed keywords

AMIKACIN; AMPICILLIN; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; NALIDIXIC ACID; NORFLOXACIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM DETECTION; BACTERIUM ISOLATION; CONTROLLED STUDY; DISK DIFFUSION; ENZYME ANALYSIS; ENZYME SYNTHESIS; ESCHERICHIA COLI; HOSPITAL; INFECTION CONTROL; INTENSIVE CARE UNIT; NONHUMAN; OUTPATIENT; POLYMERASE CHAIN REACTION; WARD;

ESCHERICHIA COLI;

EID: 67650649807     PISSN: 17273048     EISSN: 18125719     Source Type: Journal    
DOI: 10.3923/jbs.2009.362.366     Document Type: Article

References (19)

1. Apisarnthanarak, A., P. Kiratisin, P. Saifon, R. Kitphati, S. Dejsirilert and L.M. Mundy, 2007. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: A case-case-control study. Am. J. Infect. Control, 35: 606-612.
2. Apisarnthanarak, A., P. Kiratisin, P. Saifon, R. Kitphati, S. Dejsirilert and L.M. Mundy, 2008. Predictors of mortality among patienis with community-onset infection due to extended-spectrum beta-lactamase-producing Escherichia coli in Thailand. Infect. Control Hosp. Epidemiol., 29: 80-82.
3. Carattoli, A., A. Garcia-Fernandez, P. Varesi, D. Fortini, S. Gerardi, A. Penni, C. Mancini and A. Giordano, 2008. Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases isolated in Rome, Italy. J. Clin. Microbiol., 46: 103-108.
4. Clinical and Laboratory Standards Institute, 2006. Performance Standards for Antimicrobial disk Susceptibility Tests. Approved Standard. 9th Edn., Clinical and Laboratory Standards Institute, Wayne, Pennsylvania.
5. Datta, N. and P. Kontomichalou, 1965. Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature, 208: 239-241.
6. Edelstein, M., M. Pimkin, I. Palagin, I. Edelstein and L. Stratchounski, 2003. Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coll and klebsiella pneumoniae in Russian hospitals. Antimicrob. Agents. Chemother., 47: 3724-3732.
7. Fang, H., F. Maker, G. Hedin and K. Dornbusch, 2007. Molecular epidemiology of extended-spectrum {beta}-lactamases among Escherichia coli isolates in a Swedish hospital and its associated healthcare facilities in 2001-2006. J. Clin. Microbiol., 10.1128/JCM.01943-07
8. Jarlier, V., M.H. Nicolas, G. Fournier and A. Philippon, 1988. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev. Infect. Dis., 10: 867-878.
9. Kim, M.E., U.S. Ha and Y.H. Cho, 2008. Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: A multicentre study in 2006. Int. J. Antimicrob. Agents, 31: S15-S18.
10. Mehrgan, H. and M. Rahbar, 2007. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int. J. Antimicrob. Agents, 31: 147-151.
11. Mendelson, G., V. Hait, J. Ben-Israel, D. Gronich, E. Granot and R. Raz, 2005. Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur. J. Clin. Microbiol. Infect. Dis., 24: 17-22.
12. Moreno, A., H. Bello, D. Guggiana, M. Dominguez and G. Gonzalez, 2007. Extended-spectrum beta-lactamases belonging to CTX-M group produced by Escherichia coli strains isolated from companion animals treated with enrofloxacin. Vet. Microbiol., 129: 203-208.
13. Ozgunes, I., N. Erben, A. Kiremitci, E.D. Kartal and G. Durmaz et al., 2006. The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors. Saudi. Med. J., 27: 608-612.
14. Paterson, D.L., 2006. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Infect. Control, 34: S20-S28.
15. Rodriguez-Bano, J., M.D. Navarro, L. Romero, MA. Muniain and M.D. Cueto et al., 2006. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in the CTX-M era: A new clinical challenge. Clin. Infect. Dis., 43: 1407-1414.
16. Samaha-Kfoury, J.N. and G.F. Araj, 2003. Recent developments in β lactamases and extended spectrum β lactamases Br. Med. J., 327: 1209-1213.
17. Tofteland, S., B. Haldorsen, K.H. Dahl, G.S. Simonsen and M. Steinbakk et al., 2007. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta -lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J. Clin. Microbiol., 45: 199-205.
18. Tonkic, M., I. Goic-Barisic and V. Punda-Polic, 2005. Prevalence and antimicrobial resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae strains isolated in a university hospital in Split, Croatia. Int. Microbiol., 8: 119-124.
19. Yao, F., Y. Qian, S. Chen, P. Wang and Y. Huang, 2007. Incidence of extended-spectrum beta-lactamases and characterization of integrons in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Shantou, China. Acta. Biochim. Blophys. Sin (Shanghai), 39: 527-532.